High Vista Strategies LLC Akero Therapeutics, Inc. Transaction History

High Vista Strategies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$41.19 - $52.25 $469,895 - $596,068	11,408 New	11,408 $577,000
Q4 2022 Feb 14, 2023	BUY	$33.44 - $54.8 $622,953 - $1.02 Million	18,629 New	18,629 $1.02 Million
Q1 2021 May 17, 2021	SELL	$24.04 - $34.19 $666,845 - $948,396	-27,739 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$25.12 - $29.89 $696,803 - $829,118	27,739 New	27,739 $716,000

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.36B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.